A Novel Mutation (c.705C>A (p.C235*) (p.Cys235Ter)) in the SFTPB Gene That Causes Severe Respiratory Failure in A Term Newborn

References

[1] Avery, M. E., Mead, J. (1959). Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child, 97: 517-523.

[2] Chroneos, Z. C., Sever-Chroneos, Z., Shepherd, V. L. (2010). Pulmonary surfactant: An immunological perspective. Cell Physiol Biochem, 25: 13-26.

[3] Orgeig, S., Hiemstra, P. S., Veldhuizen, E. J., Casals, C., Clark, H. W., Haczku, A., Knudsen, L., and Possmayer, F. (2010). Recent advances in alveolar biology: evolution and function of alveolar proteins. Respiratory physiology & neurobiology, 173 Suppl(0), S43-S54. https://doi.org/10.1016/j.resp.2010.04.023. 

[4] Whitsett, J. A., Weaver, T. E. (2002). Mechanisms of disease: hydrophobic surfactant proteins in lung function and disease. N Engl J Med., 347: 2141-2148. 

[5] Crouch, E. C. (1998). Structure, biologic properties, and expression of surfactant protein D. Biochim Biophys Acta.. 1408: 278-289.

[6] Cole, F. S., Hamvas, A., Rubinstein, P., King, E., Trusgnich, M., Nogee, L. M., et al. (2000). Population-based estimates of surfactant protein B deficiency. Pediatrics, 105(3 Pt 1), 538-541. https://doi.org/10.1542/peds.105.3.538. 

[7] Hamvas, A. (2006). Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation. Semin Perinatol, 30: 316-326.

[8] Ueno, T., Linder, S., Na, C. L., Rice, W. R., Johansson, J., and Weaver, T. E. (2004). Processing of pulmonary surfactant protein B by napsin and cathepsin H. The Journal of biological chemistry, 279(16), 16178-16184. https://doi.org/10.1074/jbc.M312029200. 

[9] National Center for Biotechnology information, U.S National Library of Medicine, http:/ncbi.nlm.nih.gov/clinvar. (Search for SFTPB gene). Access: 23-10-2021.

[10] Hamvas, A., Trusgnich, M., Brice, H., Baumgartner, J., Hong, Y., Nogee, L. M., & Cole, F. S. (2001). Population-based screening for rare mutations: high-throughput DNA extraction and molecular amplification from Guthrie cards. Pediatric research, 50(5), 666–668. https://doi.org/10.1203/00006450-200111000-00021 

[11] Beers, M. F., Hamvas, A., Moxley, M. A., Gonzales, L. W., Guttentag, S. H., Solarin, K. O., et al. (2000). Pulmonary surfactant metabolism in infants lacking surfactant protein B. American journal of respiratory cell and molecular biology, 22(3), 380-391. https://doi.org/10.1165/ajrcmb.22.3.3645. 

[12] Li, J., Ikegami, M., Na, C. L., Hamvas, A., Espinassous, Q., Chaby, R., et al. (2004). N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding. Biochemistry, 43(13), 3891-3898. https://doi.org/10.1021/bi036218q. 

[13] Shulenin, S., Nogee, L. M., Annilo, T., Wert, S. E., Whitsett, J. A., and Dean, M. (2004). ABCA3 gene mutations in newborns with fatal surfactant deficiency. The New England journal of medicine, 350(13), 1296-1303. https://doi.org/10.1056/NEJMoa032178. 

[14] Deterding, R. R., Sontag, M., Kerby, G., et al. (2005). Clinical characteristics of surfactant protein C mutations in children. Am J Respir Crit Care Med.; abstract 2:A474. 

[15] Garmany, T. H., Moxley, M. A., White, F. V., Dean, M., Hull, W. M., Whitsett, J. A., et al. (2006). Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res. 59(6): 801-5. doi: 10.1203/01.pdr.0000219311.14291.df. Epub 2006 Apr 26. PMID: 16641205. 

[16] Brasch, F., Schimanski, S., Mühlfeld, C., Barlage, S., Langmann, T., Aslanidis, C., et al. (2006). Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med., 2006 Sep 1, 174(5): 571-80. doi: 10.1164/rccm.200509-1535OC. Epub 2006 May 25. 

[17] Yang, F., Zhang, J., Yang, Y., Ruan, F., Chen, X., Guo, J., et al. (2020). Regulatory Roles of Human Surfactant Protein B Va-riants on Genetic Susceptibility to Pseudomonas Aeruginosa Pneumonia-Induced Sepsis. Shock, 2020 Oct., 54(4): 507-519. doi: 10.1097/SHK.0000000000001494. Erratum in: Shock. 2021 Feb 1, 55(2): 284. PMID: 31851120 

[18] Munis, A. M., Hyde, S. C., Gill, D. R. (2020). A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications. Mol Ther Methods Clin Dev. 2020 Nov 20, 20:237-246. doi: 10.1016/j.omtm.2020.11.013. PMID: 33426150; PMCID: PMC7782204. 

[19] Nogee, L. M., de Mello, D. E., Dehner, L. P., Colten, H. R. (1993). Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med., 328: 406-410

[20] Eldridge, W. B., Zhang, Q,, Faro, A., et al. (2017). Outcomes of Lung Transplantation for Infants and Children with Genetic Disorders of Surfactant Metabolism. J Pediatr., May, 184:157-164.e2. doi: 10.1016/j.jpeds.2017.01.017. Epub 2017 Feb 16. PMID: 28215425; PMCID: PMC5443678.

Copyright

© 2022 by the author(s).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not modified or adapted.
https://creativecommons.org/licenses/by-nc-nd/4.0/